EJU.F - Aethlon Medical, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2023
Current
12/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
8.03M5.93M13.59M17.15M20.17M
Enterprise Value
-6.90M-11.22M-878.04k1.50M2.20M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/A0.290.44N/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
670.00191.8158.0554.1669.02
Price/Book (mrq)
0.510.290.901.011.11
Enterprise Value/Revenue
-525.94N/AN/AN/A167.92
Enterprise Value/EBITDA
0.533.940.24-0.52-0.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.18
52-Week Change 3-77.75%
S&P500 52-Week Change 31.77%
52 Week High 32.4900
52 Week Low 30.2291
50-Day Moving Average 30.3412
200-Day Moving Average 30.5106

Share Statistics

Avg Vol (3 month) 3219
Avg Vol (10 day) 3N/A
Shares Outstanding 522.97M
Implied Shares Outstanding 6N/A
Float 822.74M
% Held by Insiders 11.04%
% Held by Institutions 15.81%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Mar 31, 2022
Most Recent Quarter (mrq)Dec 31, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-100,689.45%

Management Effectiveness

Return on Assets (ttm)-38.71%
Return on Equity (ttm)-70.56%

Income Statement

Revenue (ttm)13.12k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)294.17k
EBITDA -13.02M
Net Income Avi to Common (ttm)-13.35M
Diluted EPS (ttm)-0.6800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.5M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)1.27M
Total Debt/Equity (mrq)7.37
Current Ratio (mrq)7.46
Book Value Per Share (mrq)0.75

Cash Flow Statement

Operating Cash Flow (ttm)-10.66M
Levered Free Cash Flow (ttm)-6.89M